Literature DB >> 28214206

Involvement of prolyl isomerase PIN1 in the cell cycle progression and proliferation of hepatic oval cells.

Prabodh Risal1, Nirajan Shrestha2, Lokendra Chand2, Karl G Sylvester3, Yeon Jun Jeong4.   

Abstract

Liver regenerates remarkably after toxic injury or surgical resection. In the case of failure of resident hepatocytes to restore loss, repopulation is carried out by induction, proliferation, and differentiation of the progenitor cell. Although, some signaling pathways have been verified to contribute oval cell-mediated liver regeneration, role of Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1(Pin1) in the oval cells proliferation is unknown. In the present study, we evaluate the role of Pin1 in oval cells proliferation. In our study, the expression of Pin1 in the mice liver increased after three weeks feeding of 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine (DDC) diet along with the proliferation of oval cells. The expression of Pin1 was higher in oval cells compared to the hepatocytes.Pin1 inhibition by Juglone reduced oval cell proliferation, which was restored to normal when oval cells were treated with IGF-1. Consistent with increased cell growth, expression of Pin1, β-catenin and PCNA were increased in IGF-1 treated cells in a time dependent manner. In FACS analysis, siRNA-mediated knockdown of the Pin1 protein in the oval cells significantly increased the numbers of cells in G0/G1 phase. Furthermore, hepatocyte when treated with TGF-β showed marked reduction in cell proliferation and expression of Pin1 whereas this effect was not seen in the oval cells treated with TGF-β. In conclusion, Pin1 plays important role in the cell cycle progression and increase oval cells proliferation which may be crucial in chronic liver injury.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  3, 5-Diethoxycarbonyl-1; 4-Dihydrocollidine; Hepatic progenitor cells; Liver injury; Oval cells; Peptidyl-prolyl isomerase Pin1

Mesh:

Substances:

Year:  2017        PMID: 28214206     DOI: 10.1016/j.prp.2017.01.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

1.  A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.

Authors:  Dayun Yang; Wensong Luo; Jichuang Wang; Min Zheng; Xin-Hua Liao; Nan Zhang; Wenxian Lu; Long Wang; Ai-Zheng Chen; Wen-Guo Wu; Hekun Liu; Shi-Bin Wang; Xiao Zhen Zhou; Kun Ping Lu
Journal:  J Control Release       Date:  2017-11-21       Impact factor: 9.776

Review 2.  Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.

Authors:  Yang Chen; Ya-Ran Wu; Hong-Ying Yang; Xin-Zhe Li; Meng-Meng Jie; Chang-Jiang Hu; Yu-Yun Wu; Shi-Ming Yang; Ying-Bin Yang
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

3.  The role of insulin in transdifferentiated hepatocyte proliferation and function in serum-free medium.

Authors:  Ce Gu; Panpan Li; Wei Liu; Yan Zhou; Wen-Song Tan
Journal:  J Cell Mol Med       Date:  2019-04-04       Impact factor: 5.310

Review 4.  Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.

Authors:  Jingyi Li; Chunfen Mo; Yifan Guo; Bowen Zhang; Xiao Feng; Qiuyue Si; Xiaobo Wu; Zhe Zhao; Lixin Gong; Dan He; Jichun Shao
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

Review 5.  Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.

Authors:  Hsiang-Hao Chuang; Yen-Yi Zhen; Yu-Chen Tsai; Cheng-Hao Chuang; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang
Journal:  Biomedicines       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.